Journal articles on the topic 'FDA problems'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'FDA problems.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
&NA;. "FDA: ADHD Meds May Increase Heart Problems." Nurse Practitioner 31, no. 4 (April 2006): 70. http://dx.doi.org/10.1097/00006205-200604000-00026.
Full text&NA;. "FDA Takes Aim at Infusion Pump Problems." Journal of Clinical Engineering 35, no. 4 (October 2010): 174. http://dx.doi.org/10.1097/jce.0b013e3181fdb42b.
Full textGutman, Steven I., Janie G. Fuller, and Ethan D. Hausman. "Consumers Report Glucose Meter Problems to FDA." Diabetes Technology & Therapeutics 6, no. 6 (December 2004): 767–69. http://dx.doi.org/10.1089/dia.2004.6.767.
Full textKuehn, Bridget M. "FDA: Acetaminophen May Trigger Serious Skin Problems." JAMA 310, no. 8 (August 28, 2013): 785. http://dx.doi.org/10.1001/jama.2013.276938.
Full textHaffner, Marlene E., and John V. Kelsey. "Evaluation of Orphan Products by the U.S. Food and Drug Administration." International Journal of Technology Assessment in Health Care 8, no. 4 (1992): 647–57. http://dx.doi.org/10.1017/s0266462300002348.
Full textMook, Hailey. "FDA warns about dental problems associated with buprenorphine medications." Pharmacy Today 28, no. 4 (April 2022): 49. http://dx.doi.org/10.1016/j.ptdy.2022.03.021.
Full textGershon, Diane. "FDA panel sees problems with labelling of milk hormone." Nature 363, no. 6425 (May 1993): 107. http://dx.doi.org/10.1038/363107a0.
Full textMuni, Neal I., and Thomas P. Gross. "Problems with Drug-Eluting Coronary Stents — The FDA Perspective." New England Journal of Medicine 351, no. 16 (October 14, 2004): 1593–95. http://dx.doi.org/10.1056/nejmp048262.
Full textAult Barnett, Alicia. "FDA warns Pfizer on failure to report drug problems." Lancet 347, no. 9014 (June 1996): 1546. http://dx.doi.org/10.1016/s0140-6736(96)90694-7.
Full textHan, Ling-Na, Kai-Qiang Wang, Zi-Ning Ren, Xue Yang, Xiao Duan, Sasirekha Krishnan, Abinaya Jaisankar, et al. "One-pot synthesis and enzyme-responsiveness of amphiphilic doxorubicin prodrug nanomicelles for cancer therapeutics." RSC Advances 12, no. 43 (2022): 27963–69. http://dx.doi.org/10.1039/d2ra04436f.
Full textHalabi, Sam F. "The Codex Alimentarius Commission, Corporate Influence, and International Trade: A Perspective on FDA's Global Role." American Journal of Law & Medicine 41, no. 2-3 (May 2015): 406–21. http://dx.doi.org/10.1177/0098858815591525.
Full textLiu, Qinghua, Kai Ding, Bingsen Wu, and Quanmin Xie. "Frequency Diverse Array Target Localization Based on IPSO-BP." International Journal of Antennas and Propagation 2020 (August 27, 2020): 1–8. http://dx.doi.org/10.1155/2020/2501731.
Full textTanne, Janice Hopkins. "FDA works with US health insurers to identify drug problems." BMJ 336, no. 7650 (April 24, 2008): 913.2–913. http://dx.doi.org/10.1136/bmj.39559.404560.db.
Full textYoung, Donna. "ASHP, other groups, advise FDA about solving counterfeit drug problems." American Journal of Health-System Pharmacy 60, no. 23 (December 1, 2003): 2406. http://dx.doi.org/10.1093/ajhp/60.23.2406.
Full textLew, Helen, William D. Hadesty, Karen D. Bell, Francine M. DelVecchio, and Susan T. Chin. "fda import automation: Serious management and systems development problems persist." Information & Management 30, no. 3 (June 1996): 143–53. http://dx.doi.org/10.1016/0378-7206(95)00058-5.
Full textMitka, M. "FDA Advisory Decision Highlights Some Problems Inherent in Pragmatic Trials." JAMA: The Journal of the American Medical Association 306, no. 17 (November 1, 2011): 1851–52. http://dx.doi.org/10.1001/jama.2011.1570.
Full textSpringer, Janet A., and Foster D. Mcclure. "Statistical Sampling Approaches." Journal of AOAC INTERNATIONAL 71, no. 2 (March 1, 1988): 246–50. http://dx.doi.org/10.1093/jaoac/71.2.246.
Full textReed, Terrie L., and Diana Kaufman-Rivi. "FDA Adverse Event Problem Codes: Standardizing the Classification of Device and Patient Problems Associated with Medical Device Use." Biomedical Instrumentation & Technology 44, no. 3 (May 1, 2010): 248–56. http://dx.doi.org/10.2345/0899-8205-44.3.248.
Full textWang, Yintong, Jiandong Wang, Haiyan Chen, and Bo Sun. "Semi-Supervised Local Fisher Discriminant Analysis Based on Reconstruction Probability Class." International Journal of Pattern Recognition and Artificial Intelligence 29, no. 02 (February 27, 2015): 1550007. http://dx.doi.org/10.1142/s021800141550007x.
Full textKuehn, Bridget M. "FDA Turns to Electronic “Sentinel” to Flag Prescription Drug Safety Problems." JAMA 300, no. 2 (July 9, 2008): 156. http://dx.doi.org/10.1001/jama.300.2.156.
Full textXu, YanJie, ChunYang Wang, Jian Gong, YingJian Zhao, and ChangLin Zhou. "Mainlobe maintenance for FDA-MIMO radar." AIP Advances 12, no. 8 (August 1, 2022): 085305. http://dx.doi.org/10.1063/5.0099177.
Full textKlasmeier, Coleen, and Martin H. Redish. "Off-Label Prescription Advertising, the FDA and the First Amendment: A Study in the Values of Commercial Speech Protection." American Journal of Law & Medicine 37, no. 2-3 (June 2011): 315–57. http://dx.doi.org/10.1177/009885881103700206.
Full textBonet Olivencia, Samuel, and Farzan Sasangohar. "Investigating the Food and Drug Administration Biotherapeutics Review and Approval Process: Narrative Review." JMIR Formative Research 5, no. 3 (March 4, 2021): e14563. http://dx.doi.org/10.2196/14563.
Full textKarami, Hojat, Mahdi Valikhan Anaraki, Saeed Farzin, and Seyedali Mirjalili. "Flow Direction Algorithm (FDA): A Novel Optimization Approach for Solving Optimization Problems." Computers & Industrial Engineering 156 (June 2021): 107224. http://dx.doi.org/10.1016/j.cie.2021.107224.
Full textKnopf, Alison. "FDA warns about dental problems with buprenorphine medicines dissolved in the mouth." Brown University Child & Adolescent Psychopharmacology Update 24, no. 3 (February 10, 2022): 8. http://dx.doi.org/10.1002/cpu.30656.
Full textMarwick, Charles. "FDA Funding Problems Imperil Safety of Biological Products in the United States." JAMA 279, no. 12 (March 25, 1998): 899. http://dx.doi.org/10.1001/jama.279.12.899-jmn0325-2-1.
Full textE. Aliyeva, Sona. "Problems Regarding Comorbidity of Epilepsy with Depression in Children: A Literature Review." Psychology and Mental Health Care 6, no. 4 (June 4, 2022): 01–04. http://dx.doi.org/10.31579/2637-8892/169.
Full textGraham, Cynthia A., Petra M. Boynton, and Kate Gould. "Women’s Sexual Desire." European Psychologist 22, no. 1 (January 2017): 27–38. http://dx.doi.org/10.1027/1016-9040/a000282.
Full textMagrabi, Farah, Mei-Sing Ong, William Runciman, and Enrico Coiera. "Using FDA reports to inform a classification for health information technology safety problems." Journal of the American Medical Informatics Association 19, no. 1 (January 2012): 45–53. http://dx.doi.org/10.1136/amiajnl-2011-000369.
Full textTIMBO, BABGALEH, KATHLEEN M. KOEHLER, CECILIA WOLYNIAK, and KARL C. KLONTZ. "Sulfites—A Food and Drug Administration Review of Recalls and Reported Adverse Events." Journal of Food Protection 67, no. 8 (August 1, 2004): 1806–11. http://dx.doi.org/10.4315/0362-028x-67.8.1806.
Full textEvans, Barbara J. "The Ethics of Postmarketing Observational Studies of Drug Safety Under Section 505(o)(3) of the Food, Drug, and Cosmetic Act." American Journal of Law & Medicine 38, no. 4 (December 2012): 577–606. http://dx.doi.org/10.1177/009885881203800401.
Full textGECAN, JOHN S., and STANLEY M. CICHOWICZ. "Toxic Mushroom Contamination of Wild Mushrooms in Commercial Distribution." Journal of Food Protection 56, no. 8 (August 1, 1993): 730–34. http://dx.doi.org/10.4315/0362-028x-56.8.730.
Full textBujnak, Alyssa, Carly A. Crowder, and Michael L. Krychman. "Energy-Based Devices for Functional Vaginal Problems: Issues and Answers." Current Sexual Health Reports 13, no. 1 (February 26, 2021): 1–13. http://dx.doi.org/10.1007/s11930-021-00302-x.
Full textWang, Yuzhuo, Shengqi Zhu, Lan Lan, Ximin Li, Zhixin Liu, and Zhixia Wu. "Range-Ambiguous Clutter Suppression via FDA MIMO Planar Array Radar with Compressed Sensing." Remote Sensing 14, no. 8 (April 15, 2022): 1926. http://dx.doi.org/10.3390/rs14081926.
Full textBayless, William C. "LATE PUBLICATION OF PRODUCT RECALLS BY FDA CAN CAUSE PROBLEMS FOR MANUFACTURERS AND HOSPITALS." Biomedical Safety & Standards 15, no. 12 (June 1985): 94. http://dx.doi.org/10.1097/00149078-198506150-00010.
Full textMarwick, Charles. "Nontherapeutic Problems of Generic Drugs Lead to Call for FDA, Legislative Diagnosis and Cure." JAMA: The Journal of the American Medical Association 262, no. 12 (September 22, 1989): 1566. http://dx.doi.org/10.1001/jama.1989.03430120016004.
Full textMarwick, C. "Nontherapeutic problems of generic drugs lead to call for FDA, legislative diagnosis and cure." JAMA: The Journal of the American Medical Association 262, no. 12 (September 22, 1989): 1566–67. http://dx.doi.org/10.1001/jama.262.12.1566.
Full textDempsey, James J., and Mark Ross. "Evaluation of Hardwire Personal Assistive Listening Devices." American Journal of Audiology 3, no. 2 (July 1994): 71–77. http://dx.doi.org/10.1044/1059-0889.0301.71.
Full textAbramson, Norman, Alan Meisel, and Peter Safar. "Ethical and Legal Problems in Resuscitation Research." Prehospital and Disaster Medicine 1, S1 (1985): 59–60. http://dx.doi.org/10.1017/s1049023x00043788.
Full textThomas, W. John. "The Vioxx Story: Would it Have Ended Differently in the European Union?" American Journal of Law & Medicine 32, no. 2-3 (June 2006): 365–80. http://dx.doi.org/10.1177/009885880603200210.
Full textHino, Hideitsu, and Noboru Murata. "A Conditional Entropy Minimization Criterion for Dimensionality Reduction and Multiple Kernel Learning." Neural Computation 22, no. 11 (November 2010): 2887–923. http://dx.doi.org/10.1162/neco_a_00027.
Full textLu, Kevin, and Patricia Slattum. "USING REAL-WORLD EVIDENCE TO SUPPORT THE FDA REGULATORY APPROVAL: METHODOLOGICAL CONSIDERATIONS." Innovation in Aging 6, Supplement_1 (November 1, 2022): 193. http://dx.doi.org/10.1093/geroni/igac059.770.
Full textShuster, Joel. "ADRs Causing Hospital Admissions; A Reader's Tale of Serotonin Syndrome; Adverse Effects of Laxatives; Oxcarbazepine-Induced SIADH; Two Problems with Fluoroquinolones." Hospital Pharmacy 37, no. 11 (November 2002): 1143–46. http://dx.doi.org/10.1177/001857870203701109.
Full textSun, Chunlei, Xi Rong, Yongqin Cai, Song Qiu, and Maryam Farzaneh. "Mini review: The FDA‐approved prescription drugs that induce ovulation in women with ovulatory problems." Drug Development Research 81, no. 7 (May 19, 2020): 815–22. http://dx.doi.org/10.1002/ddr.21687.
Full textVENUGOPAL, RAJESH, LINDA TOLLEFSON, FREDERICK N. HYMAN, BAB TIMBO, RONALD E. JOYCE, and KARL C. KLONTZ. "Recalls of Foods and Cosmetics by the U.S. Food and Drug Administration." Journal of Food Protection 59, no. 8 (August 1, 1996): 876–80. http://dx.doi.org/10.4315/0362-028x-59.8.876.
Full textWallin, Richard F. "Current Problems in Devices Evaluation: Some Solutions." Journal of the American College of Toxicology 7, no. 4 (July 1988): 491–97. http://dx.doi.org/10.3109/10915818809019522.
Full textDreyfus, J. F., D. Cremniter, and J. D. Guelfi. "Reflections on FDA and WHO recommendations concerning clinical trials." Psychiatry and Psychobiology 4, no. 2 (1989): 117–22. http://dx.doi.org/10.1017/s0767399x00002960.
Full textNikoobin, A., and M. Moradi. "Indirect solution of optimal control problems with state variable inequality constraints: finite difference approximation." Robotica 35, no. 1 (July 2, 2015): 50–72. http://dx.doi.org/10.1017/s0263574715000521.
Full textAzevedo, Leonardo. "Model reduction in geostatistical seismic inversion with functional data analysis." GEOPHYSICS 87, no. 1 (November 10, 2021): M1—M11. http://dx.doi.org/10.1190/geo2021-0096.1.
Full textMeléndez, Rafael, Ramón Giraldo, and Víctor Leiva. "Sign, Wilcoxon and Mann-Whitney Tests for Functional Data: An Approach Based on Random Projections." Mathematics 9, no. 1 (December 28, 2020): 44. http://dx.doi.org/10.3390/math9010044.
Full text